Jmcgh and Other sites: Non-Urine Sites Only
Numbers are
percent susceptible
|
Gram
Negative Organisms |
No. of isolates |
amk |
am/s |
cz |
fep |
caz |
cx |
esbl (+) |
etp |
gm |
le |
mer |
pip/ taz |
tmp/ smx |
|
Acinetobacter baumannii |
68 |
- |
84 |
- |
46 |
29 |
- |
- |
- |
74 |
38 |
93 |
- |
41 |
|
Citrobacter freundii |
11* |
100 |
- |
0 |
100 |
91 |
91 |
- |
100 |
82 |
82 |
100 |
- |
73 |
|
Citrobacter koseri |
13* |
100 |
- |
92 |
100 |
92 |
100 |
- |
100 |
100 |
77 |
100 |
- |
77 |
|
Enterobacter aerogenes |
17* |
100 |
- |
0 |
100 |
100 |
100 |
- |
100 |
100 |
100 |
100 |
94 |
100 |
|
Enterobacter cloacae |
77 |
100 |
- |
0 |
95 |
74 |
77 |
- |
91 |
90 |
86 |
100 |
79 |
90 |
|
Escherichia coli |
285 |
100 |
43 |
84 |
92 |
90 |
90 |
8 |
100 |
81 |
51 |
100 |
94 |
63 |
|
Klebsiella oxytoca |
27* |
100 |
85 |
70 |
100 |
100 |
100 |
0 |
100 |
100 |
100 |
100 |
100 |
100 |
|
Klebsiella pneumoniae |
104 |
100 |
84 |
92 |
92 |
92 |
92 |
8 |
100 |
98 |
91 |
100 |
98 |
96 |
|
Morganella morganii |
29* |
100 |
0 |
0 |
97 |
79 |
100 |
- |
100 |
86 |
59 |
100 |
90 |
52 |
|
Proteus mirabilis |
245 |
100 |
65 |
92 |
97 |
96 |
96 |
- |
99 |
81 |
38 |
100 |
99 |
39 |
|
Providencia stuartii |
25* |
100 |
0 |
0 |
96 |
100 |
100 |
- |
- |
52 |
20 |
100 |
88 |
56 |
|
Pseudomonas aeruginosa |
311 |
98 |
- |
- |
77 |
81 |
- |
- |
- |
83 |
58 |
82 |
85 |
- |
|
Serratia marcescens |
37 |
100 |
- |
0 |
100 |
100 |
100 |
- |
100 |
100 |
97 |
100 |
100 |
97 |
|
Stenotrophomonas maltophilia |
43/24(le)* |
- |
- |
- |
- |
- |
- |
- |
- |
|
75 |
- |
- |
91 |
*NO. of isolates-“Percent susceptible for each
organism/antimicrobial combination was generated by including the first isolate
of that organism recovered from a given patient.” When fewer that 30 isolates
are reported it should be noted that less than statistical validity of the
estimates of percent susceptibility exist.
Abbreviation Key: amk- amikacin,
am/s-ampicillin/sulbactam, cz-cefazolin,
fep- cefepime, caz-ceftazidime,
cx-ceftriaxone, esbl-Extended Spectrum Beta Lactamase,
etp-ertapenem, gm-gentamicin, le-levofloxacin,
mer-Meropenem nit-nitrofurantoin, pip/taz-piperacillin/tazobactam,
tmp/smx-trimethoprim/sulfa
- antibiotics not tested or not recommended
due to lack of correlation between in vitro results and in vivo activity.
Comments:
·
71% of Haemophilus infuenzae isolates were beta lactamase negative (95
isolates tested). Beta Lactamase negative indicates probable susceptibility to
penicillin, ampicillin and 1st generation cephalosporins. Beta lactamase positive indicates probable
resistance to ampicillin, amoxicillin and first
generation cephalosporins. Recommended therapy is
combination therapy or a third generation cephalosporin.
·
88% of Moraxella (Branhamella) catarrhalis
were beta lactamase positive (26 isolates tested). Beta lactamase positive
indicates resistance to penicillin, ampicillin and
first generation cephalosporins. Several beta-lactams are effective including beta lactam/Beta
Lactamase inhibitory combinations, 3rd generation cephalosporins, macrolides, quinolones and trimethoprim/sulfamethoxazole.
·
38 isolates of Salmonella species and 5 Shigella
species were recovered. Susceptibility testing is not routinely
performed on intestinal sites. Extraintestinal sites
are tested against ampicillin, trimethoprim/sulfa
and a third generation cephalosporin. Intestinal source isolates will be tested
per telephone request.
·
5 Campylobacter species were isolated
in 2009.
·
3 Giardia lamblia positive rapid antigens were confirmed in
2009.
·
1 Cryptosporidium positive rapid
antigens were confirmed in 2009.